People · Operator
Named in public records as an officer, director or promoter · active 2011–2013 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transenterix Inc | — | Other Health Care | Series C | $72.2M | $45.7M | 2011 |
Paul M. La Violette at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul M. La Violette on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William N. Starling | 1 | 5 |
| Todd M. Pope | 1 | 3 |
| Dennis M. Dougherty | 1 | 2 |
| Matt M. Rieke | 1 | 1 |
| Andrew M. Schiff | 1 | 1 |
| Garheng M. Kong | 1 | 1 |
| Aftab M. Kherani | 1 | 1 |
| Fred M. McCoy | 1 | 1 |
| John M. Onopchenko | 1 | 1 |
| David M. Milne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.